 | • レポートコード：MRC2-11QY12105 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は頭頸部がん治療薬のグローバル市場について調査・分析したレポートです。種類別（PD阻害剤、微小管阻害剤、EGFR阻害剤）市場規模、用途別（手術、放射線療法、化学療法、免疫療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別頭頸部がん治療薬の競争状況、市場シェア ・世界の頭頸部がん治療薬市場：種類別市場規模 2015年-2020年（PD阻害剤、微小管阻害剤、EGFR阻害剤） ・世界の頭頸部がん治療薬市場：種類別市場規模予測 2021年-2026年（PD阻害剤、微小管阻害剤、EGFR阻害剤） ・世界の頭頸部がん治療薬市場：用途別市場規模 2015年-2020年（手術、放射線療法、化学療法、免疫療法） ・世界の頭頸部がん治療薬市場：用途別市場規模予測 2021年-2026年（手術、放射線療法、化学療法、免疫療法） ・北米の頭頸部がん治療薬市場分析：米国、カナダ ・ヨーロッパの頭頸部がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの頭頸部がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の頭頸部がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの頭頸部がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Eli Lilly、Amgen、Actavis、Dr. Reddy’s Laboratories、Jiangsu Hengrui、Teva Pharmaceutical、DFG、BioXpress ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
Market Analysis and Insights: Global Head and Neck Cancer Therapeutics Market
The global Head and Neck Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Head and Neck Cancer Therapeutics Scope and Market Size
Head and Neck Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Head and Neck Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
Market segment by Type, the product can be split into
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Market segment by Application, split into
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Head and Neck Cancer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Head and Neck Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PD Inhibitors
1.4.3 Microtubule Inhibitors
1.4.4 EGFR Inhibitors
1.5 Market by Application
1.5.1 Global Head and Neck Cancer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Surgery
1.5.3 Radiation therapy
1.5.4 Chemotherapy
1.5.5 Immunotherapy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Head and Neck Cancer Therapeutics Market Perspective (2015-2026)
2.2 Global Head and Neck Cancer Therapeutics Growth Trends by Regions
2.2.1 Head and Neck Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Head and Neck Cancer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Head and Neck Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Head and Neck Cancer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Head and Neck Cancer Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Head and Neck Cancer Therapeutics Players by Market Size
3.1.1 Global Top Head and Neck Cancer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Head and Neck Cancer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Head and Neck Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Head and Neck Cancer Therapeutics Market Concentration Ratio
3.2.1 Global Head and Neck Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Head and Neck Cancer Therapeutics Revenue in 2019
3.3 Head and Neck Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Head and Neck Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Head and Neck Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Head and Neck Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Head and Neck Cancer Therapeutics Market Size (2015-2020)
6.2 Head and Neck Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Head and Neck Cancer Therapeutics Market Size (2015-2020)
7.2 Head and Neck Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Head and Neck Cancer Therapeutics Market Size (2015-2020)
8.2 Head and Neck Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Head and Neck Cancer Therapeutics Market Size (2015-2020)
9.2 Head and Neck Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Head and Neck Cancer Therapeutics Market Size (2015-2020)
10.2 Head and Neck Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Head and Neck Cancer Therapeutics Market Size (2015-2020)
11.2 Head and Neck Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Head and Neck Cancer Therapeutics Market Size (2015-2020)
12.2 Head and Neck Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Head and Neck Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Head and Neck Cancer Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Head and Neck Cancer Therapeutics Introduction
13.1.4 Sanofi Revenue in Head and Neck Cancer Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Head and Neck Cancer Therapeutics Introduction
13.2.4 Eli Lilly Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Head and Neck Cancer Therapeutics Introduction
13.3.4 Amgen Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Actavis
13.4.1 Actavis Company Details
13.4.2 Actavis Business Overview
13.4.3 Actavis Head and Neck Cancer Therapeutics Introduction
13.4.4 Actavis Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.4.5 Actavis Recent Development
13.5 Dr. Reddy’s Laboratories
13.5.1 Dr. Reddy’s Laboratories Company Details
13.5.2 Dr. Reddy’s Laboratories Business Overview
13.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Therapeutics Introduction
13.5.4 Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.5.5 Dr. Reddy’s Laboratories Recent Development
13.6 Jiangsu Hengrui
13.6.1 Jiangsu Hengrui Company Details
13.6.2 Jiangsu Hengrui Business Overview
13.6.3 Jiangsu Hengrui Head and Neck Cancer Therapeutics Introduction
13.6.4 Jiangsu Hengrui Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.6.5 Jiangsu Hengrui Recent Development
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Details
13.7.2 Teva Pharmaceutical Business Overview
13.7.3 Teva Pharmaceutical Head and Neck Cancer Therapeutics Introduction
13.7.4 Teva Pharmaceutical Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.7.5 Teva Pharmaceutical Recent Development
13.8 DFG
13.8.1 DFG Company Details
13.8.2 DFG Business Overview
13.8.3 DFG Head and Neck Cancer Therapeutics Introduction
13.8.4 DFG Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.8.5 DFG Recent Development
13.9 BioXpress
13.9.1 BioXpress Company Details
13.9.2 BioXpress Business Overview
13.9.3 BioXpress Head and Neck Cancer Therapeutics Introduction
13.9.4 BioXpress Revenue in Head and Neck Cancer Therapeutics Business (2015-2020)
13.9.5 BioXpress Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Head and Neck Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Head and Neck Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Head and Neck Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Head and Neck Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PD Inhibitors
Table 6. Key Players of Microtubule Inhibitors
Table 7. Key Players of EGFR Inhibitors
Table 8. Global Head and Neck Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Head and Neck Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Head and Neck Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Head and Neck Cancer Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Head and Neck Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Head and Neck Cancer Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Head and Neck Cancer Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Head and Neck Cancer Therapeutics Players
Table 19. Global Head and Neck Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Head and Neck Cancer Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Head and Neck Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Therapeutics as of 2019)
Table 22. Global Head and Neck Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Head and Neck Cancer Therapeutics Product Solution and Service
Table 25. Date of Enter into Head and Neck Cancer Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Head and Neck Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Head and Neck Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Head and Neck Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Head and Neck Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 35. North America Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 37. North America Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 41. Europe Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 47. China Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 49. China Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 53. Japan Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 65. India Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 67. India Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Head and Neck Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Head and Neck Cancer Therapeutics Market Share (2019-2020)
Table 71. Central & South America Head and Neck Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Head and Neck Cancer Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Head and Neck Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Head and Neck Cancer Therapeutics Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Product
Table 83. Eli Lilly Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 84. Eli Lilly Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Product
Table 88. Amgen Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 89. Amgen Recent Development
Table 90. Actavis Company Details
Table 91. Actavis Business Overview
Table 92. Actavis Product
Table 93. Actavis Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 94. Actavis Recent Development
Table 95. Dr. Reddy’s Laboratories Company Details
Table 96. Dr. Reddy’s Laboratories Business Overview
Table 97. Dr. Reddy’s Laboratories Product
Table 98. Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 99. Dr. Reddy’s Laboratories Recent Development
Table 100. Jiangsu Hengrui Company Details
Table 101. Jiangsu Hengrui Business Overview
Table 102. Jiangsu Hengrui Product
Table 103. Jiangsu Hengrui Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 104. Jiangsu Hengrui Recent Development
Table 105. Teva Pharmaceutical Company Details
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Product
Table 108. Teva Pharmaceutical Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 109. Teva Pharmaceutical Recent Development
Table 110. DFG Business Overview
Table 111. DFG Product
Table 112. DFG Company Details
Table 113. DFG Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 114. DFG Recent Development
Table 115. BioXpress Company Details
Table 116. BioXpress Business Overview
Table 117. BioXpress Product
Table 118. BioXpress Revenue in Head and Neck Cancer Therapeutics Business (2015-2020) (Million US$)
Table 119. BioXpress Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Head and Neck Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. PD Inhibitors Features
Figure 3. Microtubule Inhibitors Features
Figure 4. EGFR Inhibitors Features
Figure 5. Global Head and Neck Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Surgery Case Studies
Figure 7. Radiation therapy Case Studies
Figure 8. Chemotherapy Case Studies
Figure 9. Immunotherapy Case Studies
Figure 10. Head and Neck Cancer Therapeutics Report Years Considered
Figure 11. Global Head and Neck Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Head and Neck Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Head and Neck Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Head and Neck Cancer Therapeutics Market Share by Players in 2019
Figure 16. Global Top Head and Neck Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Head and Neck Cancer Therapeutics Revenue in 2019
Figure 18. North America Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Head and Neck Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…- 頭頸部がん診断の世界市場（～2026年） Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary g…
- 癌血管新生阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Cancer Angiogenesis Inhibitors Market The global Cancer Angiogenesis Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Angiogenesis Inhibitors Scope and Market Size …
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
- 膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…